title: TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction.
authors: Immunopathogenesis Section, National Institute of Allergy and Infectious Disease, Bethesda, Md; Division of Gastroenterology, Hepatology, and Nutrition, Children's National Medical Center, Washington, DC.
authors: Vahe
authors: V
authors: Badalyan
authors: Immunopathogenesis Section, National Institute of Allergy and Infectious Disease, Bethesda, Md.
authors: Robert
authors: R
authors: Thompson
authors: Immunopathogenesis Section, National Institute of Allergy and Infectious Disease, Bethesda, Md.
authors: Kezia
authors: K
authors: Addo
authors: Tissue Fibrosis and Repair Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
authors: Lee A
authors: LA
authors: Borthwick
authors: Tissue Fibrosis and Repair Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
authors: Andrew J
authors: AJ
authors: Fisher
authors: Janssen R&D Companies of Johnson & Johnson, Springhouse, Pa.
authors: Tatiana
authors: T
authors: Ort
authors: Genomic Technologies Section, National Institute of Allergy and Infectious Disease, Bethesda, Md.
authors: Timothy G
authors: TG
authors: Myers
authors: Immunopathogenesis Section, National Institute of Allergy and Infectious Disease, Bethesda, Md.
authors: Thomas A
authors: TA
authors: Wynn
authors: Immunopathogenesis Section, National Institute of Allergy and Infectious Disease, Bethesda, Md. Electronic address: ramalingamt@niaid.nih.gov.
authors: Thirumalai R
authors: TR
authors: Ramalingam
mesh_terms: D000818:Animals; D001249:Asthma / Q000276:immunology* / Q000628:therapy; D002478:Cells, Cultured; D005347:Fibroblasts / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D018793:Interleukin-13 / Q000276:immunology*; D053663:Interleukin-13 Receptor alpha2 Subunit / Q000235:genetics / Q000378:metabolism*; D020381:Interleukin-17 / Q000276:immunology*; D015847:Interleukin-4 / Q000276:immunology; D008168:Lung / Q000473:pathology*; D051379:Mice; D058990:Molecular Targeted Therapy; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D015854:Up-Regulation
chemical_list: D018793:Interleukin-13; D053663:Interleukin-13 Receptor alpha2 Subunit; D020381:Interleukin-17; D014409:Tumor Necrosis Factor-alpha; D015847:Interleukin-4